Is this the main reason why Guardion Health Sciences (GHSI) shares surged in the after-‎hours?

Guardion Health Sciences, (GHSI) serves as a specialist health sciences corporation in the ‎United States and its subsidiaries. The organization works in two divisions, medical food, and ‎medical devices. Medical Foods provides Lumega-Z, balanced nutrition that refills and ‎replaces the macular antioxidant pigment, and GlaucoCetin. This vision-specific medical ‎food promotes and preserves the optic nerve cells’ mitochondrial activity, as well as ‎enhancement in blood supply in the visually affected artery of glaucoma patients. While ‎medical devices division offers VectorVision’swhich designs, produces, and provides ‎standardized vision monitoring equipment and materials for clinical trials, real-world vision ‎assessment, and commercial vision testing for eyepers.‎

Get ‎the hottest stocks to trade every day before the market opens 100% ‎free. Click here ‎now. 

‎Recent Performance

In the recent session Company’s stock finished up 8.14% to $0.55. During the last 52-week, ‎the stock’s best price was $0.74, while the lowest price recorded was $0.1650. GHSI’s current ‎Market capitalization is 48.58M,and its yesterday volume was recorded 31478994 in ‎contrast with its average volume of 11,672,795.‎

Read More

In the after-market hours,the Stock price surged 32.73% to 0.73.What is the reason for ‎today’s rise in this stock? There is still no straightforward answer to the question, except for ‎‎”over-excited investors.” The truth is that the only news that has specifically impacted stocks ‎in the recent week is that Bret Scholtes, a veteran of the nutritional products industry ‎for more than a decade, will be the company’s President and Chief Executive ‎Officer and a member of the company’s Board of Directors, effective January 6, ‎‎2021.‎

Over the past nine years, Mr. Scholtes has been CEO of Omega Protein Corporation, a global ‎nutritional products company that traded on the New York Stock Exchange. The company ‎was successfully sold to a strategic buyer late last year. During his tenure at Omega, ‎annualized revenues increased by 55%, EBITDA grew by more than 70%, and Omega’s stock ‎price increased by approximately 260%.‎

Get the hottest ‎stocks to trade every day before the market opens 100% ‎free. Click here ‎now. 

Conclusion

Overall Market Condition is improving slightly since the announcement of Covid-19 vaccines. ‎However, in this case, Investors optimism is more down to Mr. Bret Scholtes’ hiring, as they ‎are hoping that he will repeat his past success stories in his new venture at Guardion Health ‎Sciences, (GHSI).‎

Related posts